Harsh Jain
Biogen Pharmachem Industries Ltd. launched its operations as an Indian company in 1995. Biogen Pharmachem share price target 2025 focuses its operations on the financial trading business that trades securities derivatives and commodities. Its investment range encompasses agro-based commodities and metals so the company can benefit from market movements.
About the Company
Biogen Pharmachem has developed a business structure which focuses on detecting profitable trades alongside effective risk management strategies. Biogen Pharmachem adjusted its business model to various market developments and regulatory changes and successfully maintained its financial sector position.
Biogen Pharmachem Business Overview
The current share value of biogen pharmachem share price target 2025 stands at ₹0.99 per share as of March 17, 2025. Experts anticipate that the stock price of this company will rise during the upcoming years. The October 2025 stock market projections indicate a minimal price rise that starts at Rs. Rs. 0.76 and Rs. 3.22.
| Metric | Details |
| Founded | 1995 |
| Headquarters | Rajkot, India |
| Industry | Biogen Pharmachem Ltd |
| Founder | Charles Weissmann, Heinz Schaller |
| Market Focus | Is in the business of trading in shares and securities |
| Key Partner | NA |
| Employees | 7,605 employees |
| Stock Symbol | NA |
Fundamentals of Biogen Pharmachem
Biogen Pharmachem operates as a trading firm which deals with shares and securities as well as various commodities. When assessing its stock investors need to analyze how biogen pharmachem share price target 2025 trades its shares as well as market conditions alongside the impact of commodity price dynamics.
| Market Cap | ₹ 64.6 Cr |
| Enterprise Value | ₹ 64.59 |
| 52 Week High/Low | ₹ 1.76 / 0.92 |
| Stock P/E | 33.38 |
| Book Value | ₹ 0.85 |
| Dividend Yield | 0.00 % |
| ROCE | 0.65 % |
| ROE | 0.61 % |
| Face Value | ₹ 1.00 |
| Price to Book Value | 1.14 |
| EPS | 0.00 |
| Debt | 0.00 |
| Promoters Holding | 0% |
Financial Performance of Biogen Pharmachem
The financial records of Biogen Pharmachem for 2024 presented a revenue total of $0.22 million. Revenue cost amounted to $0.01 million while the gross profit reached $0.2 million. The company generated operating income amounting to $0.16 million and generated a total net income of $0.26 million.
| Revenue | 22.76L |
| Net Income | -31.49L |
| Diluted EPS | 0 |
| Net Profit Margin | -138.36% |
Biogen Pharmachem Stock Price Forecast 2025 Shareholding Pattern
The company does not provide sufficient details regarding its shareholding structure to the public. The most recent and correct data regarding shareholding pattern and financial metrics can be found in official company reports or financial databases.
| HOLDING | December 2024 |
| Promoters Holding | 0% |
| Fll Holding | 0% |
| Dll Holding | 0% |
| Public Holding | 100% |
Biogen Pharmachem Stock Forecast Share Price Target 2025
Professional analysts believe biogen pharmachem share price target 2025 stock value will experience steady growth through 2025.
| Year | Price Target |
| 2025 | Rs 3.22 and Rs 0.76 |
Biogen Pharmachem Stock Price Target 2026
The upward direction of stock prices will maintain its positive path through until 2026. From January to December 2026 the stock price will grow from Rs 1.68 and Rs 4.15
| Year | Price Target |
| 2026 | Rs 4.15 and Rs 1.68 |
Biogen Pharmachem Stock Price Forecast Target 2027
The projections show that the stock price will continue growing through 2027. Research shows that the stocks in January 2027 will start trading at Rs. 1.717 before and end at Rs. 5.15.
| Year | Price Target |
| 2027 | Rs. 1.717 and Rs. 5.15 |
Biogen Pharmachem Stock Price Forecast Target 2028
The research indicates the prices will keep rising throughout the period spanning from 2028 to 2029. The market expects the stock to achieve a 3.18% increase.
| Year | Price Target |
| 2028 | NA |
Biogen Pharmachem Stock Price Forecast Target 2029
The rising trend will continue throughout 2029.
| Year | Price Target |
| 2029 | NA |
Biogen Pharmachem Stock Price Forecast Target 2030
Market conditions and company performance data will provide investors with updated forecasting information that they must track.
| Year | Price Target |
| 2030 | Rs 10.23 and Rs 3.40 |
Biogen Pharmachem Stock Price Target 2035
The long-term projection for 2035 provides information with numerous uncertain elements.
| Year | Price Target |
| 2035 | NA |
Biogen Pharmachem Stock Price Target 2040
Foresight on stock price development until 2040 requires large uncertainties because of numerous unknown factors.
| Year | Pice Target |
| 2040 | NA |
Factors Influencing Share Price Target
- Economic health alongside stock market trends affect how the biogen pharmachem share price target 2025 performs in the market.
- Changes in commodity prices affect the profitability level of the company because it conducts business through commodity trading.
- New financial market and commodities regulations affect the activities of trading operations.
- The key determinants of biogen pharmachem share price target 2025 value include financial outcomes together with strategic decisions and operational efficiency and corporate performance.
Future Growth Prospects
The trading activities of shares and commodities together with securities within Biogen Pharmachem create opportunities for the company to leverage business opportunities. The company’s future growth depends heavily on market volatility levels as well as regulatory modifications and economic market fluctuations.
Final Thought
The biogen pharmachem share price target 2025 Industries Ltd. functions in the trading field where it deals with stocks and securities along with commodities. According to different forecasting models the company will have incremental stock price improvements throughout the upcoming years. Stock investment in this entity comes with specific market uncertainties and company-related factors that create potential risks for investors.
FAQs
1. What is the primary business of Biogen Pharmachem?
Ans. Biogen Pharmachem operates as a company that specializes in trading shares, securities, commodities together with agro-based and precious metals.
2. How much does Biogen Pharmachem stock currently trade on the market?
Ans. The share price of the company stands at ₹0.99 for March 2025.
3. How does the financial industry predict Biogen Pharmachem stock price evolution until 2025?
Ans. The outlook for Biogen Pharmachem shows an increasing market value where analysts project the stock price to climb up to ₹3.22 until 2025.
Disclaimer
This information piece serves as general purpose knowledge without providing financial consultation. Small business investors should recognize that stock market investments bring uncertainty.
